References
- Martin EB, Williams A, Heidel E, Macy S, Kennel SJ, Wall JS. Peptide p5 binds both heparinase-sensitive glycosaminoglycans and fibrils in patient-derived AL amyloid extracts. Biochem Biophys Res Commun 2013;436:85–9
- Wall JS, Martin EB, Richey T, Stuckey AC, Macy S, Wooliver C, Williams A, et al. Preclinical validation of the heparin-reactive peptide p5 + 14 as a molecular imaging agent for visceral amyloidosis. Molecules 2015;20:7657–82
- Wall JS, Williams A, Wooliver C, Martin EB, Cheng X, Heidel RE, Kennel SJ. Secondary structure propensity and chirality of the amyloidophilic peptide p5 and its analogues impacts ligand binding - In vitro characterization. Biochem Biophys Rep 2016;8:89–99
- Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döbeli H, Schubert D, et al. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci USA 2005;102:17342–7